EMA – Public consultation: Draft guideline on quality aspects of phage therapy medicinal products
The aim of this guideline is to clarify the regulatory expectations for quality documentation of bacteriophage active substances and finished products for human use within marketing authorisation applications. It addresses specific aspects regarding the manufacture,...





